Kozlu, S. Et Al. 2017. Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC). Pharmazie , vol.72, no.10 , 568-570.

Kozlu, S., ŞAHİN, A., Calis, S., & ÇAPAN, Y., (2017). Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC). Pharmazie , vol.72, no.10, 568-570.

Kozlu, S. Et Al. "Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)," Pharmazie , vol.72, no.10, 568-570, 2017

Kozlu, S. Et Al. "Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)." Pharmazie , vol.72, no.10, pp.568-570, 2017

Kozlu, S. Et Al. (2017) . "Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)." Pharmazie , vol.72, no.10, pp.568-570.

@article{article, author={S. Kozlu Et Al. }, title={Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)}, journal={Pharmazie}, year=2017, pages={568-570} }